Autres langues Wayland Group Corp.

Actions

MRRCF

CA9442041062

Marché Fermé - OTC Markets Autres places de cotation 16:07:51 19/04/2024			Varia. 5j.	Varia. 1 janv.
0,000001 ^USD	0,00 %		0,00 %	0,00 %

2021	Plongée dans le business des OCABSA : Interview de Pierre Vannineuse
2019	Wayland Group Corp. fait le point sur ses progrès opérationnels au Canada et à l'échelle internationale ; fournit des prévisions de revenus pour le premier, le deuxième, le troisième et le quatrième trimestre de 2019.	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

"Class (Action) Dismissed!": Recent Interpretations Of Section 29.1 Of The Class Proceedings Act, 1992	01/12/22
RG5 Investments Inc. and Albert Sheeler cancelled the acquisition of Gardina Pharmaceutical SAS from Wayland Group Corp..	02/02/21
HEXO : A New Crop Of Securities Class Actions And Amendments To The Class Proceedings Act	24/11/20
Wayland Group Corp. Announces Board and CEO Resignation	23/04/20
CanAdelaar B.V. completed the acquisition of Maricann Inc. and certain certain other property from Wayland Group Corp. and Nanoleaf Technologies Inc.	23/04/20
CanAdelaar B.V. agreed to acquire Maricann Inc. and certain certain other property from Wayland Group Corp. and Nanoleaf Technologies Inc. for CAD 12.4 million.	09/04/20
RG5 Investments Inc. and Albert Sheeler agreed to acquire Gardina Pharmaceutical SAS from Wayland Group Corp. for CAD 0.3 million.	13/02/20
Wayland Group Corp. Announces Management Changes	13/01/20
Wayland Announces Court Approval of Amended DIP Facility	16/12/19
Wayland Group cancelled the acquisition of 97% stake in Agro Ivica Dumandzic S.R.L.	10/12/19
Maricann Group Inc. cancelled the acquisition of 51% stake in Theros Pharma Ltd.	05/12/19
Wayland Group Corp. cancelled the acquisition of 50.1% stake in Tropicana Pty Ltd.	03/12/19
ICC International Cannabis Corp. (CNSX:WRLD.U) cancelled the acquisition of 49.9% stake in Maricann B.V. from Wayland Group Corp..	13/11/19
Maricann Group Inc. cancelled the acquisition of Colma Pharmaceutical SAS on November 6, 2019.	06/11/19
Wayland Group Corp. Provides Corporate Update on Transaction, Construction and Operational Progress; Revises Revenue Guidance for 2019; Plans to Plan New Plants	31/10/19
Wayland Group Receives $5 Million Bridge Loan from Cryptologic	09/08/19
Wayland Group Corp. Announces Executive Changes	03/08/19
Wayland Group Announces Changes to the Board of Directors	08/07/19
Wayland Group Corp. Announces Delay in Filing in Audited Annual Financial Statements for the Year Ended December 31, 2018	30/04/19
Wayland Group Names Matthew McLeod as President	23/04/19

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Wayland Group Corp.

Actions

MRRCF

CA9442041062

Autres langues

Filtres